Cerebellar infarction risk in a mild COVID-19 case

Radiology Case Reports

article

Antigona Kabashi¹  Henri Fero¹  Artiona Gjini¹  Diana Dhimitri¹  Mimoza Spahiu¹  Fjolla Hyseni¹  Edlira Harizi¹  Kledisa Shemsi¹  Valon Vokshi¹  Arlind Decka¹  Asm al Amin¹  Ahm Ataullah¹  Livia Capi¹  Sepideh Jahanian¹  Fareeha Nasir¹  Ivan N. Ayala¹  Juna Musa¹  Jeton Shatri¹  Kreshnike Dedushi¹  Florim Leniqi¹  Guri Hyseni¹ 

[1] Department of Radiology, AAB College, Clinical of Radiology, University Clinical Center of Kosovo

关键词: Cerebellar infarction;    COVID-19;    SARS-COV-2;    Pulmonary thromboembolism;    SARS-COV-2 infection;    Role of MRI;   

DOI  :  10.1016/j.radcr.2022.11.005

学科分类：生物化学工程

来源: University of Washington * Department of Radiology

【 摘 要 】

Thrombotic events in SARS-COV-2 disease patients are frequent, especially in patients with comorbidities such as heart failure, hypertension, cancer, diabetes mellitus, kidney failure, vascular disease, and other pulmonary illnesses. In severe cases, in particular those of hospitalized patients with other comorbidities, the development of thrombotic events in spite of anticoagulation therapy has been observed. The main thrombotic events are pulmonary thromboembolism, cerebral ischemic stroke, and peripheral artery thrombosis. Despite the severity of SARS-COV-2 disease, some patients with the aforementioned comorbidities develop thrombotic events regardless of the severity of their SARS-COV-2 infection. In this setting, the cerebellum makes no exception as an uncommon, but still possible target for thrombotic events.

【 授权许可】

CC BY|CC BY-NC-ND